Doximity (DOCS) EBITDA Margin (2020 - 2026)

Doximity (DOCS) has reported EBITDA Margin for 7 consecutive years, with 21.48% the latest figure, recorded in Q2 2026.

• On a quarterly basis, EBITDA Margin fell 1588.0% year-over-year to 21.48% in Q2 2026; TTM through Jun 2026 was 29.6%, a 1047.0% decrease from a year earlier, with the FY2026 full-year figure at 33.33%, down 661.0% from the prior year.
• EBITDA Margin was 21.48% for Q2 2026 at Doximity, up from 17.08% in the prior quarter.
• Over five years, EBITDA Margin peaked at 47.4% in Q4 2024 and troughed at 17.08% in Q1 2026.
• A 5-year average of 33.02% and a median of 34.3% in 2022 frame the typical range for EBITDA Margin.
• Across the five-year window, EBITDA Margin surged 989 bps in 2023 and tumbled 1812 bps in 2026, its largest moves.
• Over 5 years, EBITDA Margin stood at 33.39% in 2022, then increased by 30 bps to 43.28% in 2023, then grew by 10 bps to 47.4% in 2024, then dropped by 18 bps to 38.85% in 2025, then slumped by 45 bps to 21.48% in 2026.
• The last three EBITDA Margin figures came in at 21.48% (Q2 2026), 17.08% (Q1 2026), and 38.85% (Q4 2025), per Business Quant data.